Skip to content
Home » Valentine's Day » New AstraZeneca drug shows 77% increased chance at preventing COVID-19

New AstraZeneca drug shows 77% increased chance at preventing COVID-19

AstraZeneca has created an antibody treatment to prevent COVID-19 and is seeking FDA approval.

The treatment us called AZD7442 and works as a long-acting antibody combination.

If the authorization is granted, it can be used for immunocompromised people.


The formula boosts immunity for up to a year, where other drugs last a month or two.

There are three other drugs the FDA has approved, but all work to help or treat COVID symptoms.

This drug will prevent COVID.

Data from trials shows a reduced risk for symptomatic COVID of 77%. Three quarters of trial participants had conditions that suppressed their immunity.



Categories: HealthNews

Top